association

Full identifier: http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association

Assigned to 1 class:

Minted in Nanopublication

 RA__616KtA comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RA__616KtA... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-07-03T11:41:09.959+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RA__616KtA... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RA__616KtA... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RA__616KtA... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
fanapt r see clinical studies 14 when deciding among the alternative treatments available for this condition the prescriber should consider the finding that fanapt see warnings and precaution s 5 2 patients must be titrated to an effective dose of fanapt s ee dosage and administration 2 1 and clinical studies 14 the effectiveness of fanapt in long term use that is for more than 6 weeks has not been systematically evaluated in controlled trials therefore the physician who elects to use fanapt for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient s ee dosage and administration 2 3 fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults 1 14
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T09:41:09.959Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)